NCT02629640

Brief Summary

The purpose of this study to investigate if cases of Creutzfeldt-Jakob Disease (CJD) and other forms of prion disease are being missed in older adults living within Lothian.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 10, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 14, 2015

Completed
1 month until next milestone

Study Start

First participant enrolled

January 19, 2016

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
Last Updated

June 10, 2024

Status Verified

June 1, 2024

Enrollment Period

6.2 years

First QC Date

December 10, 2015

Last Update Submit

June 7, 2024

Conditions

Keywords

vCJDprion diseasedementiaold-agesurveillancebrain bankingpublic health

Outcome Measures

Primary Outcomes (1)

  • Evidence of prion disease pathology in the Lothian population, a description of the associated clinical/pathological and epidemiological features and referral characteristics, and how this compares with other cases of prion disease.

    4.5 years

Secondary Outcomes (2)

  • Description of clinical, pathological and epidemiological characteristics of patients with atypical features of dementia in the Lothian population.

    4.5 years

  • Assessment of the suitability of methods to support an extended system of enhanced CJD surveillance in the rest of the UK.

    4.5 years

Study Arms (1)

Research Participants

Medical history questionnaire; clinical assessment and review; participant follow-up; blood or buccal sample; post mortem examination.

Other: Medical history questionnaireOther: Clinical assessment and reviewOther: Participant follow-upOther: Blood or buccal sampleOther: Post mortem examination

Interventions

Epidemiological review of past medical/dental history; residential history; occupational history; family history of neurodegenerative disease.

Research Participants

History of current illness; neurological examination including general appearance, full cognitive assessment and physical examination; MRI research brain scan.

Research Participants

Hospital patient management system; regular telephone contact with patient/representative.

Research Participants

Codon-129 genotyping; storage for future research.

Research Participants

Brain tissue donation to the Edinburgh Brain and Tissue Bank for research,including investigations for evidence of prion disease.

Research Participants

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients aged 65+ accessing NHS Lothian neurology/psychogeriatric services with atypical features of the recognised forms of dementia. Eligible patients will be identified by the local clinical team by screening their existing patient lists, as they see patients as they attend their clinic or are visited in the community. The clinic staff are asked to consult the study team to confirm the patient's eligibility.

You may qualify if:

  • Patients aged 65 years or above
  • Patients accessing NHS Lothian neurology and psychogeriatric services
  • Patients who have features atypical for the recognised forms of dementia
  • Appropriate informed consent

You may not qualify if:

  • Patients aged below 65 at time of recruitment
  • Patients diagnosed with a clear alternative demonstrable pathology

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CJD Research and Surveillance Unit, Western General Hospital

Edinburgh, EH4 2XU, United Kingdom

Location

Biospecimen

Retention: SAMPLES WITH DNA

* Blood samples * Buccal samples * Brain tissue

MeSH Terms

Conditions

Prion DiseasesDementia

Interventions

Blood Specimen CollectionAutopsy

Condition Hierarchy (Ancestors)

Central Nervous System InfectionsInfectionsCentral Nervous System DiseasesNervous System DiseasesNeurodegenerative DiseasesBrain DiseasesNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Anna M Molesworth, PhD

    University of Edinburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 10, 2015

First Posted

December 14, 2015

Study Start

January 19, 2016

Primary Completion

March 31, 2022

Study Completion

March 31, 2022

Last Updated

June 10, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations